21 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Novo Nordisk (NVO) Up on Upbeat Data From New Obesity Pill Study https://www.zacks.com/stock/news/2238077/novo-nordisk-nvo-up-on-upbeat-data-from-new-obesity-pill-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238077 Mar 08, 2024 - Novo Nordisk (NVO) stock rises as it presents encouraging efficacy data on a new investigational oral obesity pill, amycretin, at its Capital Markets Day.

Pages: 123

<<<Page 3